Literature DB >> 23073775

Association of two variants in the interleukin-6 receptor gene and premature coronary heart disease in a Chinese Han population.

Zhong Chen1, Qi Qian, Chengchun Tang, Jiandong Ding, Yi Feng, Genshan Ma.   

Abstract

Two novel single nucleotide polymorphisms (SNPs; rs7529229 and rs2228145) in the interleukin-6 receptor (IL6R) gene have recently been associated with coronary heart disease (CHD) in a European population. We sought to replicate this finding and to investigate associations of these two SNPs with the severity and clinical phenotypes of premature CHD in a Chinese Han population. A total of 418 patients were studied, including 187 cases with coronary stenosis ≥50 % or acute myocardial infarction (males < 55 years and females < 65 years) and 231 controls without documented CHD. A ligase detection reaction was performed to detect rs7529229 and rs2228145. There were no differences between the controls and premature CHD groups in the frequencies for the three genotypes and alleles of rs7529229 and rs2228145 (all P > 0.05), nor did they differ between the two groups when grouped by gender (all P > 0.05). There were also no associations between these two SNPs and the severity of coronary lesions or clinical phenotypes of premature CHD (all P > 0.05). Our results do not support an association between rs7529229 or rs2228145 with premature CHD in the Chinese Han population. Further studies are warranted to elucidate the role of these two SNPs in the development of atherosclerosis and CHD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073775     DOI: 10.1007/s11033-012-2143-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  14 in total

Review 1.  Inflammation, atherosclerosis, and coronary artery disease.

Authors:  Göran K Hansson
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

2.  Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome.

Authors:  Eduardo Esteve; Gemma Villuendas; Judith Mallolas; Joan Vendrell; Abel López-Bermejo; Matilde Rodríguez; Mónica Recasens; Wifredo Ricart; José L San Millán; Héctor Escobar-Morreale; Cristóbal Richart; José Manuel Fernández-Real
Journal:  Clin Endocrinol (Oxf)       Date:  2006-07       Impact factor: 3.478

3.  The human interleukin-6 receptor alpha chain gene is localized on chromosome 1 band q21.

Authors:  P M Kluck; J Wiegant; R P Jansen; M W Bolk; A K Raap; R Willemze; J E Landegent
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

4.  Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD.

Authors:  Chao Qiang Jiang; Tai Hing Lam; Bin Liu; Jie Ming Lin; Xiao Jun Yue; Ya Li Jin; Bernard M Y Cheung; G Neil Thomas
Journal:  Obesity (Silver Spring)       Date:  2010-02-25       Impact factor: 5.002

5.  Variation in the interleukin-6 receptor gene associates with type 2 diabetes in Danish whites.

Authors:  Yasmin H Hamid; Søren A Urhammer; Dorit P Jensen; Charlotte Glümer; Knut Borch-Johnsen; Torben Jørgensen; Torben Hansen; Oluf Pedersen
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

6.  Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.

Authors:  Martin J Boulanger; Dar-chone Chow; Elena E Brevnova; K Christopher Garcia
Journal:  Science       Date:  2003-06-27       Impact factor: 47.728

7.  The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.

Authors:  Daniel I Swerdlow; Michael V Holmes; Karoline B Kuchenbaecker; Jorgen E L Engmann; Tina Shah; Reecha Sofat; Yiran Guo; Christina Chung; Anne Peasey; Roman Pfister; Simon P Mooijaart; Helen A Ireland; Maarten Leusink; Claudia Langenberg; Ka Wah Li; Jutta Palmen; Philip Howard; Jackie A Cooper; Fotios Drenos; John Hardy; Michael A Nalls; Yun Rose Li; Gordon Lowe; Marlene Stewart; Suzette J Bielinski; Julian Peto; Nicholas J Timpson; John Gallacher; Malcolm Dunlop; Richard Houlston; Ian Tomlinson; Ioanna Tzoulaki; Jian'an Luan; Jolanda M A Boer; Nita G Forouhi; N Charlotte Onland-Moret; Yvonne T van der Schouw; Renate B Schnabel; Jaroslav A Hubacek; Ruzena Kubinova; Migle Baceviciene; Abdonas Tamosiunas; Andrzej Pajak; Roman Topor-Madry; Sofia Malyutina; Damiano Baldassarre; Bengt Sennblad; Elena Tremoli; Ulf de Faire; Luigi Ferrucci; Stefania Bandenelli; Toshiko Tanaka; James F Meschia; Andrew Singleton; Gerjan Navis; Irene Mateo Leach; Stephan J L Bakker; Ron T Gansevoort; Ian Ford; Stephen E Epstein; Mary Susan Burnett; Joe M Devaney; J Wouter Jukema; Rudi G J Westendorp; Gert Jan de Borst; Yolanda van der Graaf; Pim A de Jong; Anke-Hilse Mailand-van der Zee; Olaf H Klungel; Anthonius de Boer; Pieter A Doevendans; Jeffrey W Stephens; Charles B Eaton; Jennifer G Robinson; JoAnn E Manson; F Gerry Fowkes; Timonthy M Frayling; Jackie F Price; Peter H Whincup; Richard W Morris; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Susan Redline; Leslie A Lange; Meena Kumari; Nick J Wareham; W M Monique Verschuren; Emelia J Benjamin; John C Whittaker; Anders Hamsten; Frank Dudbridge; J A Chris Delaney; Andrew Wong; Diana Kuh; Rebecca Hardy; Berta Almoguera Castillo; John J Connolly; Pim van der Harst; Eric J Brunner; Michael G Marmot; Christina L Wassel; Steve E Humphries; Philippa J Talmud; Mika Kivimaki; Folkert W Asselbergs; Mikhail Voevoda; Martin Bobak; Hynek Pikhart; James G Wilson; Hakon Hakonarson; Alex P Reiner; Brendan J Keating; Naveed Sattar; Aroon D Hingorani; Juan Pablo Casas
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

8.  Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.

Authors:  Nadeem Sarwar; Adam S Butterworth; Daniel F Freitag; John Gregson; Peter Willeit; Donal N Gorman; Pei Gao; Danish Saleheen; Augusto Rendon; Christopher P Nelson; Peter S Braund; Alistair S Hall; Daniel I Chasman; Anne Tybjærg-Hansen; John C Chambers; Emelia J Benjamin; Paul W Franks; Robert Clarke; Arthur A M Wilde; Mieke D Trip; Maristella Steri; Jacqueline C M Witteman; Lu Qi; C Ellen van der Schoot; Ulf de Faire; Jeanette Erdmann; Heather M Stringham; Wolfgang Koenig; Daniel J Rader; David Melzer; David Reich; Bruce M Psaty; Marcus E Kleber; Demosthenes B Panagiotakos; Johann Willeit; Patrik Wennberg; Mark Woodward; Svetlana Adamovic; Eric B Rimm; Tom W Meade; Richard F Gillum; Jonathan A Shaffer; Albert Hofman; Altan Onat; Johan Sundström; Sylvia Wassertheil-Smoller; Dan Mellström; John Gallacher; Mary Cushman; Russell P Tracy; Jussi Kauhanen; Magnus Karlsson; Jukka T Salonen; Lars Wilhelmsen; Philippe Amouyel; Bernard Cantin; Lyle G Best; Yoav Ben-Shlomo; JoAnn E Manson; George Davey-Smith; Paul I W de Bakker; Christopher J O'Donnell; James F Wilson; Anthony G Wilson; Themistocles L Assimes; John-Olov Jansson; Claes Ohlsson; Åsa Tivesten; Östen Ljunggren; Muredach P Reilly; Anders Hamsten; Erik Ingelsson; Francois Cambien; Joseph Hung; G Neil Thomas; Michael Boehnke; Heribert Schunkert; Folkert W Asselbergs; John J P Kastelein; Vilmundur Gudnason; Veikko Salomaa; Tamara B Harris; Jaspal S Kooner; Kristine H Allin; Børge G Nordestgaard; Jemma C Hopewell; Alison H Goodall; Paul M Ridker; Hilma Hólm; Hugh Watkins; Willem H Ouwehand; Nilesh J Samani; Stephen Kaptoge; Emanuele Di Angelantonio; Olivier Harari; John Danesh
Journal:  Lancet       Date:  2012-03-14       Impact factor: 79.321

Review 9.  Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review.

Authors:  John Danesh; Stephen Kaptoge; Andrea G Mann; Nadeem Sarwar; Angela Wood; Sara B Angleman; Frances Wensley; Julian P T Higgins; Lucy Lennon; Gudny Eiriksdottir; Ann Rumley; Peter H Whincup; Gordon D O Lowe; Vilmundur Gudnason
Journal:  PLoS Med       Date:  2008-04-08       Impact factor: 11.069

10.  Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?

Authors:  Naveed Sattar; Heather M Murray; Paul Welsh; Gerard J Blauw; Brendan M Buckley; Stuart Cobbe; Anton J M de Craen; Gordon D Lowe; J Wouter Jukema; Peter W Macfarlane; Michael B Murphy; David J Stott; Rudi G J Westendorp; James Shepherd; Ian Ford; Chris J Packard
Journal:  PLoS Med       Date:  2009-06-23       Impact factor: 11.069

View more
  3 in total

1.  An association study between genetic polymorphism in the interleukin-6 receptor gene and coronary heart disease.

Authors:  Jiangqing Zhou; Xiaoliang Chen; Huadan Ye; Ping Peng; Yanna Ba; Xi Yang; Xiaoyan Huang; Yae Lu; Xin Jiang; Jiangfang Lian; Shiwei Duan
Journal:  Biomed Res Int       Date:  2014-05-26       Impact factor: 3.411

2.  The rs2228145 polymorphism in the interleukin-6 receptor and its association with long-term prognosis after myocardial infarction in a pilot study.

Authors:  Anna Szpakowicz; Witold Pepinski; Ewa Waszkiewicz; Małgorzata Skawronska; Anna Niemcunowicz-Janica; Wlodzimierz J Musial; Karol A Kaminski
Journal:  Arch Med Sci       Date:  2016-03-17       Impact factor: 3.318

3.  Polymorphisms and Gene-Gene Interaction in AGER/IL6 Pathway Might Be Associated with Diabetic Ischemic Heart Disease.

Authors:  Kuo Liu; Yunyi Xie; Qian Zhao; Wenjuan Peng; Chunyue Guo; Jie Zhang; Ling Zhang
Journal:  J Pers Med       Date:  2022-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.